PROACTIVE INVESTIGATORS. SECONDARY SECONDARY PREVENTION OF MACROVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES IN THE PROACTIVE STUDY (PROSPECTIVE PIOGLITAZONE CLINICAL TRIAL IN MACROVASCULAR EVENTS): A RANDOMISED CONTROLLED TRIAL

DORMANDY, J.A., CHARBONNEL, B., & ECKLAND, D.J.. (2005). PROACTIVE INVESTIGATORS. SECONDARY SECONDARY PREVENTION OF MACROVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES IN THE PROACTIVE STUDY (PROSPECTIVE PIOGLITAZONE CLINICAL TRIAL IN MACROVASCULAR EVENTS): A RANDOMISED CONTROLLED TRIAL. LANCET, 366(-), 1279-1289. SID. https://sid.ir/paper/660370/en

DORMANDY J.A., CHARBONNEL B., ECKLAND D.J.. PROACTIVE INVESTIGATORS. SECONDARY SECONDARY PREVENTION OF MACROVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES IN THE PROACTIVE STUDY (PROSPECTIVE PIOGLITAZONE CLINICAL TRIAL IN MACROVASCULAR EVENTS): A RANDOMISED CONTROLLED TRIAL. LANCET[Internet]. 2005;366(-):1279-1289. Available from: https://sid.ir/paper/660370/en

J.A. DORMANDY, B. CHARBONNEL, and D.J. ECKLAND, “PROACTIVE INVESTIGATORS. SECONDARY SECONDARY PREVENTION OF MACROVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES IN THE PROACTIVE STUDY (PROSPECTIVE PIOGLITAZONE CLINICAL TRIAL IN MACROVASCULAR EVENTS): A RANDOMISED CONTROLLED TRIAL,” LANCET, vol. 366, no. -, pp. 1279–1289, 2005, [Online]. Available: https://sid.ir/paper/660370/en